News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
New
Specialty:
Multispecialty
Allergy & Immunology
Anesthesiology
Business of Medicine
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Medical Students
Nurses
Pharmacists
Residents
Today on Medscape
Edition:
ENGLISH
DEUTSCH
ESPAÑOL
FRANÇAIS
PORTUGUÊS
Log In
Sign Up It's Free!
Edition:
ENGLISH
DEUTSCH
ESPAÑOL
FRANÇAIS
PORTUGUÊS
Register
Log In
No Results
No Results
Saturday, October 21, 2017
News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
New
close
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit.
Log out
Cancel
Hodgkin's Lymphoma
Hodgkin's Lymphoma News
Neurologic AEs on Rise as Checkpoint Inhibitors Evolve
Potentially lethal immune-related adverse events (AEs) are expected to increase as anti-PD-1 therapies for solid tumors expand to include other cancers.
Medscape Medical News
, September 11, 2017
Which Cancers Secondary to Kaposi Sarcoma Are Emerging in the HAART Era?
Reuters Health Information
, September 1, 2017
Immunotherapy in Cancer: Hits and Misses, but Charging Ahead
Medscape Medical News
, August 16, 2017
Proton Therapy Insurance Coverage: Fair or Foul?
Medscape Medical News
, August 9, 2017
Immune Checkpoint Inhibitors Effective for Advanced Urothelial, Renal Cancers
Reuters Health Information
, July 18, 2017
Odds of Pregnancy Reduced for One Third of Cancer Survivors
Medscape Medical News
, July 11, 2017
More
Hodgkin's Lymphoma Perspective
European Hematology Association (EHA) 2017 Congress
Read clinically focused news coverage of key developments from EHA 2017.
theheart.org on Medscape
, June 26, 2017
Negative Trials, CAR T Studies Lead ASH Lymphoma Highlights
Drs Ann LaCasce and Kerry Savage discuss the most interesting lymphoma studies presented at ASH 2016, including the CALGB/Alliance 50303, GOYA, and GALLIUM trials.
Medscape Oncology
, December 12, 2016
#ASCO16: Hot Topics on Twitter
Medscape Oncology
, June 29, 2016
Antibody-Drug Conjugates, Targeted Therapies Lead Lung Cancer Data
Medscape Oncology
, June 1, 2016
What's Hot in Hematologic Malignancies
Medscape Oncology
, May 27, 2016
'Releasing the Dogs’ in the Body’s War on Cancer
Ruesch Center
, February 18, 2016
More
Journals
The Spleen
BJA Education
, July 26, 2017
The Safety of Vedolizumab for the Treatment of IBD
Alimentary Pharmacology & Therapeutics
, July 25, 2017
Disparities in Adolescents and Young Adults With Cancer
Cancer Control: Journal of the Moffitt Cancer Center
, July 4, 2017
Next Steps in Immuno-Oncology: Enhancing Antitumor Effects
Annals of Oncology
, June 23, 2017
Increased Incidence of Cancer in HIV/HCV Coinfection
AIDS
, June 19, 2017
More
Medscape Drugs & Diseases: Hodgkin's Lymphoma
Hodgkin Lymphoma
Lymphomas, Endocrine, Mesenchymal, and Other Rare Tumors of the Mediastinum
Pediatric Hodgkin Lymphoma
Thoracic Hodgkin Disease Imaging
Medscape Education: Hodgkin's Lymphoma
